|
EPI UPDATE
A weekly publication by the Bureau of Epidemiology
For February 23, 2000
"The reason for collecting, analyzing and disseminating information on a
disease is to control that disease. Collection and analysis should not be allowed to
consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jill H. Parker, MSP, Epi Update Editor
Bureau of Epidemiology Frequent Contributors:
Steven
Wiersma, MD, MPH,
Deputy State Epidemiologist |
William
J. Bigler, PhD, MS,
Senior Epidemiologist |
Jodi
Baldy, MPH,
Biological Scientist IV |
Ursula
E. Bauer, PhD,
Chronic Disease Epidemiologist |
John
Werth, MA,
Bureau Education Coordinator |
Lisa
Conti, DVM, MPH,
State Public Health Veterinarian |
Regional Epidemiologists:
Dolly Katz,
PhD, MPH,
SE Florida |
Roger
Sanderson, RN, MA,
SW Florida |
Carina Blackmore, MS Vet. Med.,
PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central
Florida Carina Blackmore, MS Vet. Med., PhD, |
Gérard Krause,
MD, DTMH,
NW Florida |
Please print out this material and share with epidemiology staff,
county health department directors, administrators, medical directors, nursing directors,
environmental health directors and others with an interest in information of this type.
Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7
days a week for consultation at our main number (850/245-4401) PLEASE NOTE:
Consultation after 5 p.m. & on weekends is intended for emergencies.
In this issue:
1. Important: Proposed Revisions to Chapter 64D-3, F.A.C.
2. Malaria Prophylaxis: CDC Notice - Dominican Republic
3. Lead Poisoning Cases from a Folk Remedy in Hillsborough County
4. Florida Influenza Program Summary Update: Week 6 (week
ending February 12, 2000)
5. Influenza Sentinel Surveillance Network: Map of Influenza Activity in
Florida, January 16 through February 15, 2000
6. Florida Past Punch Cards and Electronic Tabulation
7. Weekly Disease Table: Week 7
1. Important: Proposed Revisions to Chapter 64D-3, F.A.C.
Jodi Baldy, MPH, Bureau of Epidemiology
Proposed revisions to Rule 64D-3 are in the "Notice of Rule
Making" phase. The proposed rule and supporting documents have been sent to
Department of Health (DOH) county health department directors and nursing staff directors,
the DOH laboratories, the large private laboratories, the DOH bureau chiefs, the Florida
Childrens Forum, and the childcare licensing program of the Department of Children
and Families. The proposed revisions were published in the February 11th issue
of the Florida Administrative Weekly.
The proposed amendments update the list of notifiable diseases and
conditions and procedural rules for reporting of communicable diseases and conditions. In
summary, Rule 64D-3 is being amended to:
1) clarify certain definitions;
2) add Q Fever to, and delete Amebiasis and Toxic Shock Syndrome from,
the list of notifiables;
3) clarify language related to confidentiality of reports and reports
to medical facilities;
4) add language to further define quarantine and control procedures for
specific communicable diseases;
5) clarify the definition of a sensitive situation;
6) add hepatitis A to the list of sexually transmissible diseases;
7) amend specific reporting procedures for sexually transmissible
diseases; and
8) incorporate by reference forms for reporting of congenital anomalies
and guidelines for outbreaks of enteric disease in child care settings.
Technical changes include corrections and additions to rule references
and statute citations.
If requested within 21 days of the February 11, 2000 notice published
in the Florida Administrative Weekly, a hearing will be held at the date, time and place
below:
TIME AND DATE: 9:00 a.m. on March 6, 2000.
PLACE: Department of Health, E. Carlton Prather Building, Capital
Circle Office Center, 2585 Merchants Row Blvd, Room 310-A.
Comments and responses may be made in writing via email, fax, or
regular mail to be received on or before the scheduled hearing date. Please use this
opportunity for input this is an important revision covering a number of
communicable disease issues.
The full text of the proposed rule and a copy of the enteric disease
guidelines can be found on the Bureau of Epidemiology web page at www.doh.state.fl.us (choose
epidemiology as subject). Click on the red text "Proposed Revisions to Chapter 64D-3,
F.A.C.
2. Malaria Prophylaxis: CDC Notice - Dominican Republic
Notice
In December 1999, CDC revised its recommendations for travelers to the
Altagracia Province of the Dominican Republic. This revision was based on reports of a
localized outbreak of malaria in this province, which included cases in tourists who
stayed only in resort areas. Tourists traveling to resorts in the Altagracia Province were
advised to take chloroquine prophylaxis. Control measures undertaken by the Ministry of
Health in the Dominican Republic have eliminated local transmission in and around these
resort areas. Intensified surveillance indicates that the outbreak is over. Therefore, as
of February 17, 2000, CDC is no longer recommending chloroquine prophylaxis for travelers
to resort areas in the Dominican Republic, but continues to recommend it for travelers to
rural areas of the Dominican Republic, excluding resort areas. CDC together with the
Ministry of Health in the Dominican Republic will be monitoring the situation closely.
For further information, please see CDC's Internet travel
information.
Or call the CDC voice information system.
To receive fax information.
3. Lead Poisoning Cases from a Folk Remedy in Hillsborough County
Gregg Rottler, MPH, Hillsborough County Health Department
A 6-month-old boy and his 3-year-old brother recently underwent
chelation therapy at Tampa General Hospital after blood lead levels of 83 ug/dl and 68
ug/dl, respectively, were detected. Neither child appeared to exhibit acute symptoms of
lead poisoning.
The older child was initially diagnosed with the condition after
visiting the Hillsborough County Health Departments Ruskin Clinic for a nail fungus
infection. A physical was performed on the child, which included a lead test. The younger
child was diagnosed with lead poisoning after the health departments lead
investigator, Cynthia Keeton, wasnt able to identify any environmental sources of
contamination and suggested that the entire family be tested for lead.
When questioned by the investigator about the use of home remedies, the
mother stated that she had given her children an orange-colored powder called Azarcon that
she imported from Mexico. She said she used it to treat for "empacho", a folk
term for gastrointestinal illness. An analysis from the states Jacksonville lab
indicated that the substance contained 82% lead.
The use of lead-containing folk remedies can lead to permanent
neurological impairment and death. Azarcon is known by other names including Ruedo,
Alarcon, Maria Luisa, Ligo, and Corol. It is used as an ingredient by Mexican druggists in
topical treatments for skin disorders. Another lead-containing folk remedy imported from
Mexico for empacho is Greta, which is a yellow-colored powder. Greta is sold in hardware
stores for use as a pottery glaze. The medicinal use of lead has been documented in other
ethnic communities as well.
Health care providers should routinely inquire about the use of home
remedies while performing health screenings in demographic regions with immigrant
populations. Culturally competent educational efforts stressing the health hazards
associated with these home remedies may help to reduce exposures.
Editorial Comment: Azarcon is particularly dangerous because it may be
given to children who are suffering from gastrointestinal distress that is itself a
product of lead poisoning. - RSH
4. Florida Influenza Program Summary Update: Week 6
(week ending February 12, 2000)
Roger Sanderson, RN, MA, Bureau of Epidemiology
National:
Since October 3, 1999, the World Health Organization (WHO) and the
National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories have
tested 66,810 respiratory specimens for influenza, from which 11,957 (18%) influenza
isolates have been recovered. Influenza A accounted for 11,935 of the 11,957 (99.8%)
isolates with 22 isolates being influenza B (0.2%). Of the 3,003 influenza A viruses
sub-typed 2,980 (99.2%) were A (H3N2) and 23 (0.8%) were A (H1N1). Both influenza A and B
were isolated in Florida during this time period.
During week 6, influenza activity was reported as widespread in 4
states (Arizona, New York, Pennsylvania, and Tennessee). Regional influenza activity was
reported in 17 states (Alabama, Colorado, Georgia, Indiana, Kentucky, Louisiana, Maryland,
Massachusetts, Michigan, Missouri, North Carolina, Ohio, South Carolina, Utah, Vermont,
Virginia, and Wisconsin). Sporadic influenza activity was reported in 26 states, no
influenza activity was reported in 1 state, and 2 states did not report. This continues
the decrease in overall influenza activity seen in previous weeks. During Week 5
widespread influenza activity was reported in 8 states, regional activity in 17 states and
sporadic in 21 states and 4 states did not report.
During Week 6, the proportion of deaths due to pneumonia and influenza
(P&I) was 9.9% as reported by the vital statistics offices of 122 U.S. cities. This
percentage is above the epidemic threshold of 7.6% for Week 6 and is unusually high. The
percentage of pneumonia and influenza deaths has exceeded threshold values for this time
of year for 20 of the past 21 weeks. The current seasons P&I figures must be
interpreted with caution because important changes have taken place in this years
case definition that may be contributing to higher estimates of P&I mortality than in
previous years. Tampa, St. Petersburg, Jacksonville and Miami are the Florida cities that
contributed to this report.
Florida:
Since the beginning of Week 6 (February 6, 2000) laboratory confirmed
isolates of influenza A H3N2/Sydney-like were reported from Broward, Palm Beach and
Hillsborough counties. Influnza A H3N2 has also been isolated from Alachua, Baker,
Brevard, Clay, Collier, Duval, Escambia, Gadsden, Indian River, Lake, Leon, Martin,
Miami-Dade, Orange, Pasco, Pinellas, Sarasota, and Volusia counties since October 1, 1999.
The state's second Influenza B/Yamanashi-like isolate was from a specimen collected on
February 2, 2000 from Broward County. Previously, an influenza B/Yamanashi-like isolate
was collected from Indian River County. Untyped isolates of influenza A have been reported
from Brevard, DeSoto, and Manatee counties. Antigens from both influenza A/Sydney and
influenza B/Yamanashi are included in the 1999-2000 influenza vaccine.
Of the total patient visits to sentinel physicians for Week 6, 2% were
due to ILI. This is the same as week 5 and is within the expected range of 0-3%. This week
influenza-like illness was reported from providers in 14 (Broward, Collier, Duval,
Escambia, Hillsborough, Indian River, Leon, Marion, Palm Beach, Pasco, Pinellas, Polk,
Sarasota, and St. Lucie counties) of the 29 Florida counties participating in the National
Sentinel Physicians Surveillance Network.
Florida has experienced a decline in influenza activity since the first
week in January when the ILI in peaked at 5%. This was one week later than the national
peak at 6% during Week 52.
5. Influenza Sentinel Surveillance Network: Map of Influenza Activity
in Florida, January 16 through February 15, 2000
Carina Blackmore, MS Vet Med, PhD
6. Florida Past Punch Cards and
Electronic Tabulation
William J. Bigler, PhD
When working computerized files it is hard to imagine just how difficult it might have
been to sort records and compile information when it had to be done by hand. The following
excerpt from the State Board of Health 1921-22 Annual Report announced a
technological breakthrough that made data analysis considerably easier for the public
health researchers of that time. New equipment was added and modifications were made over
the years. Still, this basic system of record management and data tabulation for morbidity
and mortality information remained essentially the same until computers entered the scene
in the mid-1960s.
A punch card is made for each
birth and death record and for each case of notifiable disease. This punch card is a
history record and provides the means by which all tabulations are compiled.
Fifty-one thousand five hundred and ninety-five (51,595) punch cards
were made for records received during 1921, and sixty-three thousand one hundred and
forty-one (63,141) for 1922, making a total of one hundred and fourteen thousand seven
hundred and thirty-six (114,736) cards punched.
In order to tabulate the records by months, by cities, by counties, by
diseases or any other way desired, the cards are sent through the sorting machine. This
electrical machine sorts the cards at the rate of one hundred and sixty (160) per minute,
and in addition to the speed accomplished, the advantage of mechanical accuracy must not
be overlooked.
After the cards are sorted they are sent through the electrical
tabulating machine and the totals taken off for the information as sorted. This system of
tabulating is modern in every way, so that we feel proud of the department and equipment
which makes it possible to keep the health index up-to-date and available for all
departments and health workers within the state.
The punch cards are carefully filed and preserved so that if special
studies in research work for diseases or other information is desired, there will be no
trouble in tabulating the information for a period of years.
7. Weekly Disease Table: Week 7
County-Confirmed Cases, Sorted Alphabetically by Disease
(NR represents years that the disease lacked status as a reportable condition)
DISEASE |
1997 TO DATE |
1998 TO DATE |
1999 TO DATE |
3 YEAR AVERAGE
TO DATE |
1999 TOTAL CASES |
2000 TO DATE |
| Amebiasis |
3 |
2 |
2 |
2.3 |
63 |
0 |
| Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
| Botulism |
0 |
0 |
0 |
0 |
4 |
0 |
| Brucellosis |
0 |
0 |
0 |
0 |
3 |
0 |
| Campylobacteriosis |
65 |
57 |
65 |
62.3 |
949 |
52 |
| Ciguatera |
0 |
0 |
0 |
0 |
2 |
0 |
| Cryptosporidiosis |
4 |
12 |
2 |
6 |
166 |
5 |
| Cyclosporiasis |
0 |
0 |
0 |
0 |
6 |
0 |
| Dengue |
0 |
0 |
1 |
0.3 |
5 |
1 |
| Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
| E. coli O157:H7 |
5 |
2 |
3 |
3.3 |
54 |
2 |
| E. coli, other (known
serotype) |
1 |
0 |
1 |
0.7 |
14 |
1 |
| Ehrlichiosis, Human |
0 |
0 |
0 |
0 |
2 |
0 |
| Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
2 |
0 |
| Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
3 |
0 |
| Encephalitis, other (known
organism) |
1 |
2 |
0 |
1 |
5 |
0 |
| Encephalitis, post-infectious1 |
0 |
0 |
1 |
0.3 |
12 |
0 |
| Giardiasis (acute) |
98 |
96 |
80 |
91.3 |
1260 |
48 |
| Haemophilus influenzae,
invasive1 |
2 |
10 |
5 |
5.7 |
48 |
1 |
| Hansens Disease (Leprosy) |
0 |
0 |
0 |
0 |
3 |
0 |
| Hantavirus Infection |
0 |
0 |
0 |
0 |
0 |
0 |
| Hemolytic Uremic Syndrome |
0 |
0 |
0 |
0 |
7 |
0 |
| Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
| Hepatitis A |
46 |
52 |
42 |
46.7 |
776 |
39 |
| Hepatitis B |
15 |
19 |
19 |
17.7 |
546 |
23 |
| Hepatitis C2 |
NR |
NR |
NR |
NR |
53 |
2 |
| Hepatitis Non-A, Non-B |
3 |
7 |
0 |
3.3 |
10 |
1 |
| Hepatitis, perinatal B2 |
NR |
NR |
NR |
NR |
2 |
0 |
| Hepatitis, unspecified |
0 |
0 |
0 |
0 |
14 |
3 |
| Hepatitis, +HBsAg, pregnant woman2 |
NR |
NR |
NR |
NR |
147 |
12 |
| Lead Poisoning |
85 |
188 |
24 |
99 |
856 |
53 |
| Legionellosis |
1 |
6 |
4 |
3.7 |
30 |
7 |
| Leptospirosis |
0 |
0 |
0 |
0 |
1 |
0 |
| Listeriosis2 |
NR |
NR |
NR |
NR |
32 |
3 |
| Lyme Disease |
0 |
1 |
1 |
0.7 |
49 |
1 |
| Malaria |
7 |
2 |
8 |
5.7 |
86 |
1 |
| Measles |
0 |
1 |
0 |
0.3 |
2 |
0 |
| Meningococcal Disease (N.
meningitidis) |
23 |
15 |
14 |
17.3 |
133 |
20 |
| Meningitis, Group B Streptococci |
2 |
1 |
2 |
1.7 |
16 |
0 |
| Meningitis, Haemophilus
influenzae1 |
2 |
3 |
2 |
2.3 |
13 |
0 |
| Meningitis, Streptococcus
pneumoniae |
12 |
19 |
17 |
16 |
95 |
16 |
| Meningitis, Listeria
monocytogenes |
0 |
1 |
0 |
0.3 |
11 |
1 |
| Meningitis, other bacterial
(including unspecified) |
3 |
4 |
4 |
3.7 |
62 |
5 |
| Mercury Poisoning |
0 |
0 |
0 |
0 |
7 |
0 |
| Mumps |
3 |
2 |
0 |
1.7 |
6 |
0 |
| Neurotoxic Shellfish Poisoning2 |
0 |
0 |
0 |
0 |
0 |
0 |
| Pertussis |
1 |
8 |
3 |
4 |
80 |
1 |
| Pesticide Poisoning |
0 |
1 |
0 |
0.3 |
32 |
1 |
| Plague |
0 |
0 |
0 |
0 |
0 |
0 |
| Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
| Psittacosis |
0 |
0 |
0 |
0 |
0 |
0 |
| Rabies, Animal |
39 |
24 |
21 |
28 |
176 |
14 |
| Rocky Mountain Spotted Fever |
1 |
0 |
0 |
0.3 |
3 |
0 |
| Rubella, including congenital |
0 |
0 |
0 |
0 |
1 |
0 |
| Salmonellosis |
129 |
148 |
146 |
141 |
2968 |
105 |
| Shigellosis |
103 |
102 |
99 |
101.3 |
1454 |
84 |
| Smallpox2 |
NR |
NR |
NR |
NR |
0 |
0 |
| Staphylococcus aureus,
(GISA/VISA)2 |
NR |
NR |
NR |
NR |
1 |
0 |
| Staphylococcus aureus,
(GRSA/VRSA)2 |
NR |
NR |
NR |
NR |
0 |
0 |
| Streptococcal Disease, invasive
Group A |
1 |
3 |
8 |
4 |
99 |
9 |
| Streptococcus pneumoniae,
invasive disease |
29 |
62 |
43 |
44.7 |
714 |
134 |
| Tetanus |
0 |
0 |
0 |
0 |
3 |
0 |
| Toxic Shock Syndrome |
0 |
2 |
0 |
0.7 |
8 |
0 |
| Toxoplasmosis |
1 |
3 |
0 |
1.3 |
15 |
0 |
| Typhoid Fever |
1 |
4 |
3 |
2.7 |
23 |
0 |
| Vibrio cholerae (serogrp
O1) |
0 |
0 |
0 |
0 |
1 |
0 |
| Vibrio cholerae (serogrp
Non-O1) |
1 |
0 |
2 |
1 |
9 |
0 |
| Vibrio vulnificus |
1 |
0 |
1 |
0.7 |
22 |
0 |
| Vibrio other (including
unspecified) |
0 |
0 |
3 |
1 |
47 |
3 |
| Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |
1 Haemophilus influenzae can be the agent responsible for disease under
three of the reportable conditions listed-: "Haemophilus influenzae,
invasive" and under "Encephalitis, post infectious." Cases of Haemophilus
influenzae meningitis are reported under "Meningitis, H. influenzae."
2 Total cases for 1999 may only reflect a six month time period since the disease
was not reportable until July 1999.
|